Zusammenfassung
Aufgrund der Interaktion zwischen den Organsystemen und wegen gemeinsamer Risikofaktoren leiden Patienten mit Lungenerkrankungen häufig zusätzlich an extrapulmonalen Erkrankungen. Im Rahmen dieses Beitrags sollen daher die Auswirkungen ausgewählter Erkrankungen des respiratorischen Systems auf das Herz-Kreislauf-System und die Niere genauer betrachtet werden. Eine fortgeschrittene chronisch-obstruktive Lungenerkrankung (COPD) führt häufig zu einer prognostisch ungünstigen Druckerhöhung im Lungenkreislauf. Therapeutisch steht diesbezüglich die Therapie der zugrunde liegenden Lungenerkrankung im Vordergrund, die gezielte Therapie der pulmonalen Hypertonie sollte nur gemäß der invasiven Diagnostik und individualisiert erfolgen. Bislang völlig unbeachtet bleibt, dass es erhebliche Überschneidungen von COPD und Herzinsuffizienz mit erhaltener Ejektionsfraktion gibt, was beim diagnostischen Prozedere berücksichtigt werden sollte. Die obstruktive Schlafapnoe (OSA) wirkt sich auf vielfältige Weise ungünstig auf das Herz-Kreislauf-System aus und ist ein unabhängiger Risikofaktor für kardiovaskuläre Erkrankungen. „Continuous positive airway pressure“ stellt die etablierte Therapie der OSA dar und verbessert Tagesmüdigkeit und Lebensqualität, ein Effekt auf kardiovaskuläre Ereignisse konnte in randomisierten Studien insbesondere für asymptomatische Patienten bislang allerdings nicht nachgewiesen werden. Patienten mit chronischer Hyperkapnie leiden häufig unter peripheren Ödemen. Pathophysiologisch sind hier neben der pulmonalen Vasokonstriktion auch direkte Auswirkungen der Hyperkapnie auf die renale Durchblutung von Bedeutung. Die Rekompensation dieser Patienten erfordert neben der Gabe von Diuretika immer auch die Korrektur der Hyperkapnie mittels nichtinvasiver Beatmungstherapie.
Abstract
Comorbidities are frequently observed in patients suffering from pulmonary diseases due to shared risk factors and intricate interactions between various organ systems. This article aims to characterize the effects of selected diseases of the respiratory system on the cardiovascular system and kidneys. Advanced chronic obstructive pulmonary disease (COPD) often leads to a prognostically unfavorable increased pressure in the pulmonary circulation. In this respect treatment of these patients is primarily aimed at the underlying pulmonary disease and targeted treatment of the pulmonary hypertension should only be carried out according to invasive diagnostics and in an individualized manner. So far, the fact that there is a substantial overlap between COPD and heart failure with preserved ejection fraction has been completely ignored, which should be considered in the diagnostic procedure. Obstructive sleep apnea (OSA) has several unfavorable effects on the cardiovascular system and has been identified as an independent risk factor for cardiovascular diseases. The established treatment of OSA with continuous positive airway pressure (CPAP) has been shown to improve daytime sleepiness and the quality of life; however, an effect of CPAP on the occurrence of cardiovascular events, especially in asymptomatic patients, has so far not been demonstrated in randomized trials. Peripheral edema is frequently observed in patients suffering from chronic hypercapnia, which can be explained by several pathophysiological mechanisms, including pulmonary vasoconstriction and a direct effect of the hypercapnia on renal blood flow. Apart from the administration of diuretics, recompensation of such patients always requires treatment of the hypercapnia by noninvasive ventilation.
Literatur
Almeneessier AS, Nashwan SZ, Al-Shamiri MQ et al (2017) The prevalence of pulmonary hypertension in patients with obesity hypoventilation syndrome: a prospective observational study. J Thorac Dis 9:779–788. https://doi.org/10.21037/jtd.2017.03.21
Anand IS, Chandrashekhar Y, Ferrari R et al (1992) Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation 86:12–21
Badr MS, Javaheri S (2019) Central sleep apnea: a brief review. Curr Pulmonol Rep 8:14–21. https://doi.org/10.1007/s13665-019-0221-z
Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M et al (2012) Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 307:2161–2168. https://doi.org/10.1001/jama.2012.4366
Baudouin SV (1997) Oedema and cor pulmonale revisited. Thorax 52:401–402. https://doi.org/10.1136/thx.52.5.401
Chaouat A, Bugnet A‑S, Kadaoui N et al (2005) Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172:189–194. https://doi.org/10.1164/rccm.200401-006OC
Cowie MR, Woehrle H, Wegscheider K et al (2015) Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med 373:1095–1105. https://doi.org/10.1056/NEJMoa1506459
Cuttica MJ, Kalhan R, Shlobin OA et al (2010) Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med 104:1877–1882. https://doi.org/10.1016/j.rmed.2010.05.009
Dodds S, Williams LJ, Roguski A et al (2020) Mortality and morbidity in obstructive sleep apnoea-hypopnoea syndrome: results from a 30-year prospective cohort study. ERJ Open Res 6:57–2020. https://doi.org/10.1183/23120541.00057-2020
Dreher M, Kabitz H‑J (2012) Impact of obesity on exercise performance and pulmonary rehabilitation. Respirology 17:899–907. https://doi.org/10.1111/j.1440-1843.2012.02151.x
Eulenburg C, Wegscheider K, Woehrle H et al (2016) Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis. Lancet Respir Med 4:873–881. https://doi.org/10.1016/S2213-2600(16)30244-2
Galiè N, Humbert M, Vachiery J‑L et al (2016) 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 37:67–119. https://doi.org/10.1093/eurheartj/ehv317
Gami AS, Olson EJ, Shen WK et al (2013) Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 62:610–616. https://doi.org/10.1016/j.jacc.2013.04.080
Giles TL, Lasserson TJ, Smith BJ et al (2006) Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 1:CD1106. https://doi.org/10.1002/14651858.CD001106.pub2
Gredic M, Blanco I, Kovacs G et al (2021) Pulmonary hypertension in chronic obstructive pulmonary disease. Br J Pharmacol 178:132–151. https://doi.org/10.1111/bph.14979
Javaheri S, Shukla R, Zeigler H, Wexler L (2007) Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 49:2028–2034. https://doi.org/10.1016/j.jacc.2007.01.084
Javaheri SS, Barbe F, Campos-Rodriguez F et al (2017) Sleep apnea: types, mechanisms, and clinical cardiovascular consequence. J Am Coll Cardiol 69:841–858. https://doi.org/10.1016/j.jacc.2016.11.069
Kasai T, Kasagi S, Maeno K et al (2013) Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC Heart Fail 1:58–63. https://doi.org/10.1016/j.jchf.2012.11.002
Kessler R, Faller M, Fourgaut G et al (1999) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:158–164. https://doi.org/10.1164/ajrccm.159.1.9803117
Lange TJ, Baron M, Seiler I et al (2014) Outcome of patients with severe ph due to lung disease with and without targeted therapy. Cardiovasc Ther 32:202–208. https://doi.org/10.1111/1755-5922.12084
Manthous CA, Mokhlesi B (2016) Avoiding management errors in patients with obesity hypoventilation syndrome. Ann Am Thorac Soc 13(1):109–114. https://doi.org/10.1513/AnnalsATS.201508-562OT
Masa JF, Mokhlesi B, Benítez I et al (2020) Echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome long-term pickwick randomized controlled clinical trial. Am J Respir Crit Care Med 201:586–597. https://doi.org/10.1164/rccm.201906-1122OC
Nathan SD, Barbera JA, Gaine SP et al (2020) Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. https://doi.org/10.1183/13993003.01914-2018
Oldenburg O, Arzt M, Bitter T et al (2015) Positionspapier „Schlafmedizin in der Kardiologie“. Kardiologe 9:140–158. https://doi.org/10.1007/s12181-015-0654-8
Olschewski H (2021) The challenge to decide between pulmonary hypertension due to chronic lung disease and PAH with chronic lung disease. Diagnostics 11:311. https://doi.org/10.3390/diagnostics11020311
Olschewski H, Behr J, Bremer H et al (2016) Pulmonale Hypertonie bei Lungenkrankheiten
Peker Y, Glantz H, Eulenburg C et al (2016) Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea: the RICCADSA randomized controlled trial. Am J Respir Crit Care Med 194:613–620. https://doi.org/10.1164/rccm.201601-0088OC
Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200. https://doi.org/10.1093/eurheartj/ehw128
Raurich J‑M, Rialp G, Ibáñez J et al (2010) Hypercapnic respiratory failure in obesity-hypoventilation syndrome: CO response and acetazolamide treatment effects. Respir Care 55:1442–1448
Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA (2018) A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation 138(9):861–870. https://doi.org/10.1161/CIRCULATIONAHA.118.034646
Riemann D, Baum E, Cohrs S et al (2017) S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie 21:2–44. https://doi.org/10.1007/s11818-016-0097-x
Scharf SM, Iqbal M, Keller C et al (2002) Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 166:314–322. https://doi.org/10.1164/rccm.2107027
Sharkey RA, Mulloy EMT, O’Neill SJ (1999) The acute effects of oxygen and carbon dioxide on renal vascular resistance in patients with an acute exacerbation of COPD. Chest 115:1588–1592. https://doi.org/10.1378/chest.115.6.1588
da Silva BC, Kasai T, Coelho FM et al (2017) Fluid redistribution in sleep apnea: therapeutic implications in edematous states. Front Med 4:256. https://doi.org/10.3389/fmed.2017.00256
da Silva Paulitsch F, Zhang L (2019) Continuous positive airway pressure for adults with obstructive sleep apnea and cardiovascular disease: a meta-analysis of randomized trials. Sleep Med 54:28–34. https://doi.org/10.1016/j.sleep.2018.09.030
Stuck BA, Arzt M, Fietze I et al (2020) Partial update of the German S3 guideline sleep-related breathing disorders in adults: AWMF register-no. 063-001—German sleep society (deutsche Gesellschaft für Schlafforschung und Schlafmedizin – DGSM). Somnologie 24:176–208. https://doi.org/10.1007/s11818-020-00257-6
Thabut G, Dauriat G, Stern JB et al (2005) Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 127:1531–1536. https://doi.org/10.1378/chest.127.5.1531
Valli G, Fedeli A, Antonucci R et al (2004) Water and sodium imbalance in COPD patients. Monaldi Arch Chest Dis 61:112–116. https://doi.org/10.4081/monaldi.2004.708
Wells JM, Washko GR, Han MK et al (2012) Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med 367:913–921. https://doi.org/10.1056/NEJMoa1203830
Windisch W, Dreher M, Geiseler J et al (2017) Guidelines for non-invasive and invasive home mechanical ventilation for treatment of chronic respiratory failure—update 2017. Pneumologie 71:722–795. https://doi.org/10.1055/s-0043-118040
Windisch W, Dreher M, Geiseler J et al (2017) S2k-Leitlinie: Nichtinvasive und invasive Beatmung als Therapie der chronischen respiratorischen Insuffizienz – Revision 2017. Pneumologie 71:722–795. https://doi.org/10.1055/s-0043-118040
Xie C, Zhu R, Tian Y, Wang K (2017) Association of obstructive sleep apnoea with the risk of vascular outcomes and all-cause mortality: a meta-analysis. BMJ Open 7:e13983. https://doi.org/10.1136/bmjopen-2016-013983
Yeboah J, Redline S, Johnson C et al (2011) Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an adult population: MESA. Atherosclerosis 219:963–968. https://doi.org/10.1016/j.atherosclerosis.2011.08.021
Cherneva Z, Valev D, Youroukova V et al (2021) Left ventricular diastolic dysfunction in non-severe chronic obstructive pulmonary disease—a step forward in cardiovascuar comorbidome. PLoS ONE. https://doi.org/10.1371/journal.pone.0247940
Huang WM, Cheng HM, Yu WC et al (2020) The ventilatory abnormalities and prognostic values of H2FPEF scorew in dypnoeic patients with preserved left ventricle systolic function. Esc Heart Fail 7:1872–1879. https://doi.org/10.1002/ehf2.12754
Huang WM, Feng JY, Cheng HM et al (2020) The role of pulmonary function in patients with heart failure and preserved ejection fraction: looking beyond chronic obstructive pulmonary disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0235152
Zeder K, Avian A, Bachmeier G et al (2021) Elevated pulmonary vascular resistance predicts mortality in COPD patients. Eur Respir J. https://doi.org/10.1183/13993003.00944-2021
Selim B, Ramar K (2021) Sleep-related breathing disorders: when CPAP is not enough. Neurotherapeutics 18:81–90. https://doi.org/10.1007/s13311-020-00955-x
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
T. Müller, J.-H. Blohm, M. Dreher und C.F. Vogelmeier geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Redaktion
B. Andrew Remppis, Bad Bevensen
Vedat Schwenger, Stuttgart
Claus F. Vogelmeier, Marburg
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Müller, T., Blohm, JH., Dreher, M. et al. Chronisch-obstruktive Lungenerkrankung, schlafbezogene Atemstörungen und Hypoventilation – Einflüsse auf das kardiorenale System. Internist 62, 1166–1173 (2021). https://doi.org/10.1007/s00108-021-01169-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-021-01169-9
Schlüsselwörter
- Pulmonale Hypertonie
- Schlafapnoe
- Alveoläre Hypoventilation
- Ödeme
- Herzinsuffizienz mit erhaltener linksventrikulärer Pumpfunktion